Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)

NCT04978818 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

333

Enrollment

OTHER

Sponsor class

Conditions

Haemophilus Influenzae Type B Infection

Interventions

DRUG: Vaxelis
DRUG: PedvaxHIB

Sponsor

Johns Hopkins Bloomberg School of Public Health

Collaborators

[object Object]